US경제·CNBC Business RSS· 번역 중
AI가 열심히 번역 중이에요 🤖
곧 한글 번역본을 제공해드릴게요. 잠시만 기다려주세요!
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
2026.06.30 06:56
AI 감성 분석
롱 (매수 신호)롱 73%숏 27%
FDA의 PreCheck 파일럿 프로그램 선정은 릴리 및 레제네론의 제조 운영 효율성 증대로 이어져 긍정적인 모멘텀을 창출할 것으로 판단됩니다.
핵심 요약
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
Original Article
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
Source: https://www.cnbc.com/2026/06/29/eli-lilly-regeneron-in-fda-precheck-manufacturing-program.html